News Releases

Date	Title	Document
Date Apr 28, 2022	Title Oncocyte to Announce First Quarter 2022 Financial Results	Document PDF
Date Apr 27, 2022	Title Oncocyte to Present New Data at ASCO 2022 Underpinning Pan-Cancer Clinical Utility of DetermaIO™	Document PDF
Date Apr 13, 2022	Title Oncocyte Corporation Announces Pricing of Public Offering of Common Stock and Warrants	Document PDF
Date Apr 13, 2022	Title Oncocyte Corporation Announces Proposed Public Offering of Common Stock and Warrants	Document PDF
Date Apr 13, 2022	Title Oncocyte Corporation Announces Pricing of Registered Direct Offering of 11,765 Shares of Series A Convertible Preferred Stock	Document PDF
Date Apr 11, 2022	Title Oncocyte Presents Confirmatory Data for DetermaIO™ at the American Association for Cancer Research Annual Meeting 2022	Document PDF
Date Mar 28, 2022	Title Oncocyte to Present New Data Confirming Association of IO Score with Response to Immunotherapy Treatment for Bladder Cancer at the American Association for Cancer Research Annual Meeting 2022	Document PDF
Date Mar 10, 2022	Title Oncocyte Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update	Document PDF
Date Mar 01, 2022	Title Oncocyte to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday March 10	Document PDF
Date Feb 10, 2022	Title Oncocyte to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	Document PDF